| Literature DB >> 26240139 |
Lin Lin1, Srila Gopal1, Anish Sharda1, Freda Passam1, Sheryl R Bowley1, Jack Stopa1, Guangpu Xue2, Cai Yuan2, Barbara C Furie1, Robert Flaumenhaft1, Mingdong Huang1, Bruce Furie3.
Abstract
Quercetin-3-rutinoside inhibits thrombus formation in a mouse model by inhibiting extracellular protein disulfide isomerase (PDI), an enzyme required for platelet thrombus formation and fibrin generation. Prior studies have identified PDI as a potential target for novel antithrombotic agents. Using a fluorescence enhancement-based assay and isothermal calorimetry, we show that quercetin-3-rutinoside directly binds to the b' domain of PDI with a 1:1 stoichiometry. The binding of quercetin-3-rutinoside to PDI induces a more compact conformation and restricts the conformational flexibility of PDI, as revealed by small angle x-ray scattering. The binding sites of quercetin-3-rutinoside to PDI were determined by studying its interaction with isolated fragments of PDI. Quercetin-3-rutinoside binds to the b'x domain of PDI. The infusion of the b'x fragment of PDI rescued thrombus formation that was inhibited by quercetin-3-rutinoside in a mouse thrombosis model. This b'x fragment does not possess reductase activity and, in the absence of quercetin-3-rutinoside, does not affect thrombus formation in vivo. The isolated b' domain of PDI has potential as an antidote to reverse the antithrombotic effect of quercetin-3-rutinoside by binding and neutralizing quercetin-3-rutinoside.Entities:
Keywords: PDI; coagulation factor; fibrin; isoquercetin; mouse; platelet; protein-disulfide isomerase; quercetin-3-rutinoside; thrombosis; thrombus formation
Mesh:
Substances:
Year: 2015 PMID: 26240139 PMCID: PMC4583019 DOI: 10.1074/jbc.M115.666180
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157